Importance of TNF-α in the course of acute infection with Trypanosoma cruzi: Influence of its inhibition by pentoxifylline treatment

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 1, 2008, Pages 21-26

  Andrade, Sonia G ^a   Magalhães, Lorena Dos Anjos ^a   Pessina, Daniel Huber ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Necrosis; Pentoxifylline; Spleen; TNF ; Trypanosoma cruzi

Indexed keywords

MUS; TRYPANOSOMA CRUZI;

EID: 41149123437     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762008005000006     Document Type: Article

References (31)

1. Aliberti JCS, Souto JT, Marino APMP, Lannes-Vieira J, Teixeira MM, Farber J, Gazzinelli RT, Silva JS 2001. Modulation of chemokine production and inflammatory responses in interferon-γ and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
2. Andrade SG, Magalhães JB 1997. Biodemes and zimodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30: 27-35.
3. Andrade V, Barral-Netto M, Andrade SG 1985. Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain. Braz J Med Biol Res 18: 499-506.
4. Andrade ZA 1991. Pathogenesis of Chagas' disease. Res Immunol 142: 126-129.
5. Andrade ZA, Miziara HL 1983. Alterações do sistema de gênese e condução do estímulo cardíaco na fase aguda de doença de Chagas humana. Arq Bras Cardiol 40: 233-237.
6. Bernard C, Barnier P, Merval R, Esposito B, Tedgui A 1995. Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall. J Cardiovasc Pharmacol 25 (Suppl. 2): 30-33.
7. Cardillo F, Voltarelli JC, Reed SG, Silva JS 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 64: 128-134.
8. Cordeiro MZ, Dahia ACG, Andrade ZA 1997. Kinetics of Trypanosoma cruzi destruction in the mouse spleen. Rev Soc Bras Med Trop 30: 3-9.
9. Doherty GM, Jensen JC, Alexander HR, Buresh CM, Norton JA 1991. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110: 192-198.
10. Dos-Reis G 1997. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol Today 13: 335-342.
11. Gazzinelli RT, Oswald IP, Hilenys S, James SL, Sher A 1992. The microbicidal activity of IFNg treated macrophages against Trypanosoma cruzi involves an 1-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by IL-10 and TGF-b. Eur J Immunol 22: 2501-2506.
12. He Q, Sharma RP 2005. Inhibition of tumor necrosis factor α signaling by anti-tumor necrosis factor α antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice. Toxicon 48: 404-413.
13. Lima ES, Andrade ZA, Andrade SG 2001. TNF-α is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi. Int J Exp Pathol 82: 327-336.
14. Magalhães-Santos I, Andrade SG 2005. Participation of cytokines in the necrotic-inflammatory lesions in the heart and skeletal muscles of Calomys callosus infected with Trypanosoma cruzi. Mem Inst Oswaldo Cruz 100: 555-561.
15. Magalhães-Santos I, Souza MM, Lima CSC, Andrade, SG 2004. Infection of Calomys callosus (Rodentia Cricetidae) with strains of different Trypanosoma cruzi biodemes: pathogenicity, histotropism, and fibrosis induction. Mem Inst Oswaldo Cruz 99: 407-413.
16. Mandell GL 1995. Cytokines, phagocytes, and pentoxifylline. J Cardiovasc Pharmacol 25 (Suppl.2): 20-22.
17. Marques LJ, Zeng L, Poulakis N, Guzman J, Costabel U 1999. Pentoxifylline inhibits TNF-a production from alveolar macrophages. Am J Respir Crit Care Med 159: 508-511.
18. Ralph I, Nakoinz R 1975. Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257: 393-394.
19. Reed WR, De Gowin RL 1992. Supressive effect of pentoxifylline on natural killer cell activity. J Lab Clin Med 119: 763-771.
20. Russo M, Starobinas N, Ribeiro dos Santos R, Minoprio P, Eisen H, Hontebeyrie-Joskowicz M 1989. Susceptible mice present higher macrophage activation than resistant mice during infection with myotropic strains of Trypanosoma cruzi. Parasite Immunol 11: 385-395.
21. Sá de Oliveira T, Capp MN, Martins BJA, Rodrigues HA, Antonino RMP, Magalhães AV 2000. Action of pentoxifylline on experimental cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 95: 477-482.
22. Samlaska MCP, Winfield MC 1994. Pentoxifylline. J Am Acad Dermatol 30: 603-617.
23. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ 1995. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63: 4862-4867.
24. Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowic M 1991. Is TNF-α involved in early susceptibility of Trypanosoma cruzi infected C3H/He mice? Res Immunol 142: 117-122.
25. Sullivan GW, Carper HT, Novick JR WJ, Mandell GL 1988. Inhibition of the inflammatory action of Interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56: 1722-1729.
26. Tarleton RL 1988. Tumour necrosis factor (cachectin) production during experimental Chagas' disease. Clin Exp Immunol 73: 186-190.
27. Teixeira MM, Gazzinelli RT, Silva JS 2002. Chemokines inflammation and Trypanosoma cruzi infection. Trends Parasitol 18: 262-265.
28. Truyens C, Torrico F, Lucas R, Baetselier P, Buurman WA, Carlier Y 1999. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun 67: 5579-5586.
29. Van Furth R, Van Shadewijk-Neuswstad M, Elzenga-Claasen I, Cornelisse C, Nibbring P 1985. Morphological, cytochemical, functional, and proliferative characteristics of four murine macropohage-like cell Lines. Cell Immunol 90: 339-357.
30. Ward A, Clissold SP 1987. Pentoxifylline - A review of its pharmacodynamics and pharmacokinetic properties and its therapeutic efficacy. Drugs 34: 50-97.
31. Wenisch C, Looareesuwan S, Wilairatana P, Parschalk B, Vannapann S, Wanaratana V, Werndorfer W, Graninger W 1998. Effect of Pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am J Trop Med Hyg 58: 343-347.